Jennifer Gudeman
Chief Tech/Sci/R&D Officer bij AVADEL PHARMACEUTICALS PLC
Profiel
Jennifer Gudeman is currently the Vice President-Medical & Clinical Affairs at Avadel Pharmaceuticals Plc since 2020.
Prior to this, she worked as the Director-Medical Affairs at AMAG Pharma USA, Inc. and as the Vice President-Medical Affairs at AMAG Pharmaceuticals, Inc. Dr. Gudeman completed her undergraduate degree in 1999 and her doctorate degree in 2000 from St. Louis College of Pharmacy.
Actieve functies van Jennifer Gudeman
| Bedrijven | Functie | Begin |
|---|---|---|
| AVADEL PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 07-12-2020 |
Eerdere bekende functies van Jennifer Gudeman
| Bedrijven | Functie | Einde |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
AMAG Pharma USA, Inc.
 AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG PHARMA USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Jennifer Gudeman
| St. Louis College of Pharmacy | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AVADEL PHARMACEUTICALS PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology AMAG PHARMA USA, Inc. engages in the provision of pharmaceutical products to independent pharmacies, managed care organizations, hospitals, pharmacy benefit management companies, government entities, and physicians. The company was founded by Victor M. Hermelin in 1942 and is headquartered in Waltham, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
